Vabicaserin Hydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVabicaserin Hydrochloride
Drug Alias Namevabicaserinum็›้…ธๆˆŠๅก่‰ฒๆž—ๆˆŠๅก่‰ฒๆž—็›้…ธ็›vabicaserinaๆˆŠๅก่‰ฒๆž— +[8]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China +[4]ย 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG